Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Hadaschik

Showing results (101-110 of 269) with videos related to

Pageof 27
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2013
PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancerAli Afshar-Oromieh, Uwe Haberkorn, Boris Hadaschik, et al.
Aktuelle Urologie|May 17, 2017
[Significance and Value of PSMA Ligands in Prostate Cancer]Claudia Gasch, Stefan Körber, Christophe Kremer, et al.
Urologia Internationalis|June 9, 2026
Clinical impact of immune checkpoint inhibitors and Chemotherapy in the first-line treatment of metastatic urothelial carcinoma with variant histologyAykhan Isgandarov, Mulham Al-Nader, Umut Ulas Yesilyurt, et al.
Trials|April 24, 2026
PRIMA: randomized prospective multicenter non-inferiority study for primary diagnosis of clinically significant PRostate cancer by PSA and MR IMAging-study protocol for a randomized diagnostic accuracy trialRouvier Al-Monajjed, Peter Albers, Matthias Boschheidgen, et al.
Clinical Genitourinary Cancer|January 19, 2015
Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer centerSonia Vallet, Sascha Pahernik, Thomas Höfner, et al.
The Lancet. Oncology|November 4, 2021
Nuclear medicine theranostics comes of ageKen Herrmann, Bernd Joachim Kraus, Boris Hadaschik, et al.
American Journal of Physiology. Cell Physiology|April 10, 2002
Regulation of transferrin-induced endocytosis by wild-type and C282Y-mutant HFE in transfected HeLa cellsLukas Schwake, Andreas W Henkel, Hans D Riedel, et al.
Pathology Oncology Research : POR|July 19, 2018
Nuclear Localization of Robo is Associated with Better Survival in Bladder CancerUlrich Krafft, Henning Reis, Marc Ingenwerth, et al.
BMC Urology|August 27, 2024
Mortality from prostate cancer in the years 2007-2021 in North Rhine-Westphalia, GermanyKevin Claaßen, Madeleine Karpinski, Hiltraud Kajüter, et al.
The Journal of Urology|November 7, 2017
Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused UltrasoundRoman Ganzer, Boris Hadaschik, Sascha Pahernik, et al.
Pageof 27

Showing results (101-110 of 269) with videos related to

Sort By:
Pageof 27
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2013
PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancerAli Afshar-Oromieh, Uwe Haberkorn, Boris Hadaschik, et al.
Aktuelle Urologie|May 17, 2017
[Significance and Value of PSMA Ligands in Prostate Cancer]Claudia Gasch, Stefan Körber, Christophe Kremer, et al.
Urologia Internationalis|June 9, 2026
Clinical impact of immune checkpoint inhibitors and Chemotherapy in the first-line treatment of metastatic urothelial carcinoma with variant histologyAykhan Isgandarov, Mulham Al-Nader, Umut Ulas Yesilyurt, et al.
Trials|April 24, 2026
PRIMA: randomized prospective multicenter non-inferiority study for primary diagnosis of clinically significant PRostate cancer by PSA and MR IMAging-study protocol for a randomized diagnostic accuracy trialRouvier Al-Monajjed, Peter Albers, Matthias Boschheidgen, et al.
Clinical Genitourinary Cancer|January 19, 2015
Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer centerSonia Vallet, Sascha Pahernik, Thomas Höfner, et al.
The Lancet. Oncology|November 4, 2021
Nuclear medicine theranostics comes of ageKen Herrmann, Bernd Joachim Kraus, Boris Hadaschik, et al.
American Journal of Physiology. Cell Physiology|April 10, 2002
Regulation of transferrin-induced endocytosis by wild-type and C282Y-mutant HFE in transfected HeLa cellsLukas Schwake, Andreas W Henkel, Hans D Riedel, et al.
Pathology Oncology Research : POR|July 19, 2018
Nuclear Localization of Robo is Associated with Better Survival in Bladder CancerUlrich Krafft, Henning Reis, Marc Ingenwerth, et al.
BMC Urology|August 27, 2024
Mortality from prostate cancer in the years 2007-2021 in North Rhine-Westphalia, GermanyKevin Claaßen, Madeleine Karpinski, Hiltraud Kajüter, et al.
The Journal of Urology|November 7, 2017
Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused UltrasoundRoman Ganzer, Boris Hadaschik, Sascha Pahernik, et al.
Pageof 27